Evidence map›Paper›PMID 33893476›Full record

ArticleArchives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists2022

Familial Idiopathic Basal Ganglia Calcification: A Father-Son Dyad Demonstrate Heterogeneity of Presentation and Disease Progression.

Evan Zahniser, Thomas D Bird, Dong-Hui Chen, Shu-Ching Hu, Wendy H Raskind, Emily H Trittschuh

Open access · hybridAbstract read
In one paragraph

Article in Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Evan Zahniser
Thomas D Bird
Dong-Hui Chen
Shu-Ching Hu
Wendy H Raskind
Emily H Trittschuh
University of Washington · USGeriatric Research Education and Clinical Center · US

Funding

Next Generation gene discovery in neurogeneticsR01NS069719 · NINDS · UNIVERSITY OF WASHINGTON · PI RASKIND, WENDY H · 2010 to 2019
$5.0M
Genetic Movement Disorders: Etiologies and PathogenesesI01CX001702 · VA · VA PUGET SOUND HEALTHCARE SYSTEM · PI CYRUS P ZABETIAN · 2018 to 2026
–
CSRD VA I01 CX001702NIH HHS 1R01NS069719NINDS NIH HHS R01 NS069719United States Department of Defense CX001702
6 · The paper itself

Abstract

objectiveFamilial idiopathic basal ganglia calcification (FIBGC) is a rare, heritable disease characterized by calcium deposition in the basal ganglia and other brain regions. Clinical presentations are diverse, featuring an array of neurologic, psychiatric, and/or cognitive symptoms. This dyad report presents neurogenetic, neuroimaging, neurological, and serial neuropsychological data from a father (S1) and son (S2) with FIBGC. METHOD/

resultsThe SLC20A2 genetic mutation c.1828-1831delTCCC was identified for each patient, both of whom evidenced similar patterns of brain calcification mainly in the basal ganglia and cerebellum on neuroimaging. S1's onset was in his late 60s with primary motor abnormalities followed by cognitive decline; S2's younger onset (late 30s) was characterized by predominant psychiatric symptoms and mild cognitive changes. Our unique, detailed longitudinal study revealed that both subjects demonstrated largely stable performance across most neuropsychological domains assessed.

conclusionsThe subjects' differences in presentation demonstrate the variable expressivity in FIBGC even with the same pathogenic variant within a single family. Distinct phenotypes may be associated with age of onset even in persons with the same mutation, consistent with past research. Disease progression may feature an initial period of notable change from baseline followed by relative stability, as seen both on imaging and neuropsychological evaluation.

Indexed as

FathersSodium-Phosphate Cotransporter Proteins, Type IIIBasal Ganglia DiseasesCalcinosisDisease ProgressionHumansLongitudinal StudiesMaleNeurodegenerative DiseasesNeuropsychological TestsNuclear FamilySLC20A2 protein, humanSodium-Phosphate Cotransporter Proteins, Type IIIBasal ganglia calcificationCase reportLongitudinalNeurogenetics

Identifiers

PMID33893476
PMCPMC8763112
OpenAlexW3153438590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.